Litigation Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
✉ Email this page to a colleague
ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-04-09 |
Court | District Court, D. New Jersey | Date Terminated | 2022-07-27 |
Cause | 15:1126 Patent Infringement | Assigned To | Brian R. Martinotti |
Jury Demand | None | Referred To | Jessica S. Allen |
Parties | ADAPT PHARMA OPERATIONS LIMITED; OPIANT PHARMACEUTICALS, INC. | ||
Patents | 7,977,376; 9,211,253; 9,468,747; 9,480,644; 9,561,177; 9,707,226 | ||
Attorneys | CHARLES MICHAEL LIZZA; CHRISTINE A. GADDIS | ||
Firms | Gibbons P.C.; Saul Ewing Arnstein & Lehr LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.
Details for ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-04-09 | 1 | 7,977,376 B2 7/2011 Singh et al .............…United States Patent Nos. 9,480,644 (the “’644 patent”) and 9,707,226 (the “’226 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patent-in-suit 12. On November 1, 2016, the United States Patent and Trademark… the ’644 patent, entitled, “Nasal Drug Products and Methods of Their Use.” The ’644 patent is assigned | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |